RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. (RAPT) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
RAPT · net income · updated Jun 8, 2026
Core profitability metrics
RAPT · net income · margin · TTM · CAGRNet income was −$129.9M for FY2024 (fiscal year ending 2024-12-31), down 11.2% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · RAPT net income history · RAPT profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
RAPT Therapeutics, Inc. (RAPT) reported net income of −$129.9M for FY2024 (fiscal year ending 2024-12-31), down 11.2% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
RAPT Therapeutics, Inc. has not yet achieved annual profitability based on available data (8 fiscal years). The company has reported net losses across all available periods.
RAPT Therapeutics, Inc.'s net profit margin was — for FY2024, based on the latest annual results.
Investors sometimes search for "RAPT Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from RAPT net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
RAPT net income · 4 questionsRAPT Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $129.9M for FY2024.
▸ Source: FMP /income-statement · GAAP · RAPT Therapeutics, Inc. · RAPT Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026